JP6183849B2 - Skin cleanser composition - Google Patents
Skin cleanser composition Download PDFInfo
- Publication number
- JP6183849B2 JP6183849B2 JP2013256864A JP2013256864A JP6183849B2 JP 6183849 B2 JP6183849 B2 JP 6183849B2 JP 2013256864 A JP2013256864 A JP 2013256864A JP 2013256864 A JP2013256864 A JP 2013256864A JP 6183849 B2 JP6183849 B2 JP 6183849B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- skin
- sodium
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 41
- -1 fatty acid salt Chemical class 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 20
- 239000000194 fatty acid Substances 0.000 claims description 20
- 229930195729 fatty acid Natural products 0.000 claims description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 10
- 239000003945 anionic surfactant Substances 0.000 claims description 10
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 9
- 239000011975 tartaric acid Substances 0.000 claims description 9
- 235000002906 tartaric acid Nutrition 0.000 claims description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 7
- 239000001630 malic acid Substances 0.000 claims description 7
- 235000011090 malic acid Nutrition 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 3
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 2
- 239000000284 extract Substances 0.000 description 75
- 239000006260 foam Substances 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 16
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000003240 coconut oil Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 9
- 238000005187 foaming Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 230000007794 irritation Effects 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000019864 coconut oil Nutrition 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 241001474374 Blennius Species 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229960004418 trolamine Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 229920006322 acrylamide copolymer Polymers 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 235000020712 soy bean extract Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 241000546188 Hypericum Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 244000288377 Saxifraga stolonifera Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229920000800 acrylic rubber Polymers 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 2
- 229940069638 aloe vera leaf extract Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229940124274 edetate disodium Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 229940071085 lauroyl glutamate Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JJKPAMUONHRVLQ-ZOWNYOTGSA-N (2s)-2-(dodecanoylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)N[C@@H](C)C(O)=O JJKPAMUONHRVLQ-ZOWNYOTGSA-N 0.000 description 1
- BZDYJNDRVBFBLD-FYZYNONXSA-N (2s)-2-(octadecanoylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(O)=O BZDYJNDRVBFBLD-FYZYNONXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- YPDCDBRKWQYBPV-UHFFFAOYSA-N 2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)NCCN(CCO)CC(O)=O YPDCDBRKWQYBPV-UHFFFAOYSA-N 0.000 description 1
- DABQDIXIAXPQFG-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]ethanesulfonic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O DABQDIXIAXPQFG-UHFFFAOYSA-N 0.000 description 1
- GFOBSZSXQKGNMN-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O GFOBSZSXQKGNMN-UHFFFAOYSA-N 0.000 description 1
- WTSYMWLXBLQPFD-UHFFFAOYSA-N 2-[ethyl(tetradecanoyl)amino]ethanesulfonic acid Chemical class CCCCCCCCCCCCCC(=O)N(CC)CCS(O)(=O)=O WTSYMWLXBLQPFD-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LPDGWMLCUHULJF-UHFFFAOYSA-N 3-piperidin-1-ylpropanoic acid Chemical compound OC(=O)CCN1CCCCC1 LPDGWMLCUHULJF-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- AMHBMSCZRBABOR-UHFFFAOYSA-N CCCCCCCCCCCC(=O)N(CC)CCS(O)(=O)=O Chemical class CCCCCCCCCCCC(=O)N(CC)CCS(O)(=O)=O AMHBMSCZRBABOR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001648859 Lilium candidum Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- KCFRUUYAXCDZNZ-UHFFFAOYSA-N N-dodecanoyltaurine Chemical class CCCCCCCCCCCC(=O)NCCS(O)(=O)=O KCFRUUYAXCDZNZ-UHFFFAOYSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 241000580938 Sapindus Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 241001296405 Tiso Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QGVQVNIIRBPOAM-UHFFFAOYSA-N dodecyl naphthalene-1-sulfonate;sodium Chemical compound [Na].C1=CC=C2C(S(=O)(=O)OCCCCCCCCCCCC)=CC=CC2=C1 QGVQVNIIRBPOAM-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 229940105040 geranium extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035909 sensory irritation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- QKJPFZCCZMBRFB-UHFFFAOYSA-M sodium;3-aminopropanoate Chemical compound [Na+].NCCC([O-])=O QKJPFZCCZMBRFB-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Description
本発明は皮膚洗浄剤組成物に関し、詳しくは、泡立ち、泡質(クリーミィ性)が良好であり、皮膚に刺激がなく、角栓除去効果に優れ、経時低温安定性にも優れた皮膚洗浄剤組成物に関する。 The present invention relates to a skin cleanser composition, and more particularly, a skin cleanser with good foaming and foam quality (creaminess), no irritation to the skin, excellent horn plug removal effect, and excellent low-temperature stability over time. Relates to the composition.
近年、多くの女性の肌悩みとして、毛穴の目立ちが挙げられる。毛穴の目立ちは毛穴に角栓が詰まることにより起こるものである。角栓は鼻や鼻周りなどの皮脂分泌の多い部位に見られ、毛穴の黒ずみや開きなどの原因となる。また角栓に対するケアが遅れるとアクネ菌が繁殖し、ニキビの原因となるため、角栓を除去することは美容上好ましい行為である。しかしながら、角栓は皮脂と古い角質が混ざって凝固し、一体化して形成されているため、通常の洗浄剤やクレンジングによる洗顔では除去効果は充分に得られない。また、シート剤やパックによる角栓の除去方法が提案されているが、粘着性により肌に負担がかかったり、剥離する前に乾燥させるための放置時間が必要であるなどの使用方法が煩雑であるため、簡便な角栓の除去方法が望まれていた。 In recent years, the conspicuous pores can be cited as a skin trouble for many women. The conspicuous pores are caused by clogged plugs. Square plugs are found in areas where there is a lot of sebum secretion, such as the nose and around the nose, which causes darkening and opening of pores. Also, if care for keratin plugs is delayed, acne bacteria will propagate and cause acne, so removing horn plugs is a cosmetically preferable action. However, since the keratin plugs are formed by mixing and sebuming sebum and old keratin, the effect of removal cannot be sufficiently obtained by washing with a normal cleaning agent or cleansing. In addition, methods for removing square plugs with sheets and packs have been proposed, but the usage method is complicated, such as that it takes a burden on the skin due to adhesiveness, and it takes a long time to dry before peeling. For this reason, a simple method for removing horn plugs has been desired.
このような状況に対し、乳酸、クエン酸、酒石酸、マロン酸、マロン酸、コハク酸、シュウ酸、リンゴ酸、イソクエン酸、グリコール酸、アスパラギン酸、グルタミン酸、ピロリドンカルボン酸の群から選ばれる有機酸及び/又はその塩を含有する角栓再生抑制剤(例えば、特許文献1参照。)が知られている。しかしながら、効果を上げるために有機酸類の配合量を増やすと肌荒れや感覚刺激が起こる場合があり、化粧品として一般的に使用することは難しかった。そこで、肌荒れを起こさずに効果的に角栓の再生を抑制する方法が提案されている。このようなものとしては、乳酸、コハク酸、クエン酸、リンゴ酸、サリチル酸、ピロリドンカルボン酸、グリコール酸、およびそれらの塩の中から選ばれる1種または2種以上と、脂肪酸石けん、高級アルキル硫酸エステル塩、N−アシル低級アルキルタウリン塩、ベタイン系界面活性剤、およびポリオキシアルキレンフィトステロールの中から選ばれる1種または2種以上の界面活性剤と、ポリオキシエチレン・ポリオキシプロピレンジメチルエーテル、トラネキサム酸、パントテニルエチルエーテル、オトギリソウ、セリン、トリメチルグリシン、アラニン、グリシルグリシン、ビタミンEアセテート、ビタミンEニコチネート、1−ピペリジンプロピオン酸、およびそれらの塩から選ばれる1種または2種以上を含有する角栓除去抑制剤(例えば、特許文献2参照。)が知られている。しかしながら、このような角栓除去抑制剤を洗浄剤として用いた場合、たとえば脂肪酸石けんと有機酸を組み合わせると泡立ちが悪くなるという課題があった。 For this situation, an organic acid selected from the group of lactic acid, citric acid, tartaric acid, malonic acid, malonic acid, succinic acid, oxalic acid, malic acid, isocitric acid, glycolic acid, aspartic acid, glutamic acid, pyrrolidone carboxylic acid In addition, a horn plug regeneration inhibitor (for example, see Patent Document 1) containing a salt thereof and / or a salt thereof is known. However, increasing the blending amount of organic acids to increase the effect may cause rough skin or sensory irritation, and it has been difficult to use it generally as a cosmetic. Therefore, a method for effectively suppressing the regeneration of the horn plug without causing rough skin has been proposed. Examples thereof include one or more selected from lactic acid, succinic acid, citric acid, malic acid, salicylic acid, pyrrolidone carboxylic acid, glycolic acid, and salts thereof, fatty acid soap, higher alkyl sulfuric acid. One or more surfactants selected from ester salts, N-acyl lower alkyl taurine salts, betaine surfactants, and polyoxyalkylene phytosterols, polyoxyethylene / polyoxypropylene dimethyl ether, tranexamic acid Horn containing 1 type or 2 or more types selected from pantothenyl ethyl ether, hypericum, serine, trimethylglycine, alanine, glycylglycine, vitamin E acetate, vitamin E nicotinate, 1-piperidinepropionic acid, and salts thereof Suppression of stopper removal (E.g., see Patent Document 2.) Are known. However, when such a horn plug removal inhibitor is used as a cleaning agent, for example, when fatty acid soap and an organic acid are combined, there is a problem that foaming becomes worse.
一方、洗浄剤として、アシル塩型アニオン性界面活性剤と有機酸とを含有する洗浄剤組成物(例えば、特許文献3参照。)が知られているが、必ずしも角栓除去効果があるものではなく、またペースト状ないし固形状であるため、フォーマー容器に充填して用いることはできない。 On the other hand, as a cleaning agent, a cleaning composition containing an acyl salt type anionic surfactant and an organic acid (for example, see Patent Document 3) is known. In addition, since it is pasty or solid, it cannot be used by filling a former container.
本発明は上記事情に鑑みてなされたもので、泡立ち、泡質(クリーミィ性)が良好であり、皮膚に刺激がなく、角栓除去効果に優れ、経時低温安定性にも優れた皮膚洗浄剤組成物を提供することを目的とする。 The present invention has been made in view of the above circumstances, and is a skin cleanser that has good foaming, foam quality (creaminess), has no irritation to the skin, is excellent in removing plugs, and has excellent low-temperature stability over time. An object is to provide a composition.
本発明者らは、本発明の目的を達成するために鋭意研究した結果、特定の有機酸と特定の界面活性剤を組み合わせ、さらにpHが特定範囲にある皮膚洗浄剤組成物が、泡立ち、泡質(クリーミィ性)が良好であり、皮膚に刺激がなく、角栓除去効果に優れ、経時低温安定性にも優れていることを見出し、本発明を完成させた。 As a result of diligent research to achieve the object of the present invention, the present inventors have combined a specific organic acid with a specific surfactant, and furthermore, a skin cleansing composition having a pH in a specific range is It has been found that the quality (creamy property) is good, the skin is not irritating, the horn plug removal effect is excellent, and the low-temperature stability over time is also excellent, and the present invention has been completed.
すなわち、本発明の角栓除去用皮膚洗浄剤組成物は、下記成分(a)及び(b)を含有し、pHが3〜4.6であることを特徴とするものである。
(a)乳酸、リンゴ酸、及び酒石酸から選ばれる1種以上
(b)下記一般式(1)で表されるN−アシルタウリン型陰イオン性界面活性剤
R1CO−NR2−CH2CH2SO3M ……… (1)
〔上式中、R1は炭素数7〜19の飽和または不飽和の炭化水素基を表し、R2は水素原子または炭素数1〜3のアルキル基を表し、Mはアルカリ金属原子、アルカリ土類金属原子、アンモニウム、または有機アミンを表す。〕
That is, the skin cleansing composition for removing horn plugs of the present invention contains the following components (a) and (b), and has a pH of 3 to 4.6 .
(A) One or more kinds selected from lactic acid, malic acid, and tartaric acid (b) N-acyl taurine type anionic surfactant represented by the following general formula (1) R 1 CO—NR 2 —CH 2 CH 2 SO 3 M (1)
[In the above formula, R 1 represents a saturated or unsaturated hydrocarbon group having 7 to 19 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, M represents an alkali metal atom, alkaline earth Represents a metal atom, ammonium, or organic amine. ]
本発明によれば、泡立ち、泡質(クリーミィ性)が良好であり、皮膚に刺激がなく、角栓除去効果に優れ、経時低温安定性にも優れた皮膚洗浄剤組成物を提供することができる。 According to the present invention, it is possible to provide a skin cleanser composition having good foaming, foam quality (creamy property), no irritation to the skin, excellent horn plug removal effect, and excellent low-temperature stability over time. it can.
以下、本発明の皮膚洗浄剤組成物について詳細に説明する。 Hereinafter, the skin cleansing composition of the present invention will be described in detail.
本発明の皮膚洗浄剤組成物で用いられる成分(a)は、乳酸、リンゴ酸、及び酒石酸から選ばれるものであり、1種単独でも2種以上を混合して用いてもよい。これらのなかでも、特に酒石酸を用いることが好ましい。成分(a)の配合量は好ましくは全組成中0.01〜5質量%(以下、単に「%」と記す。)であり、より好ましくは0.1〜2.5%である。配合量が0.01%以上であれば角栓の除去効果が充分に得られ、5%以下であれば皮膚刺激を起こすこともなく、低温化で析出することもない。また、本発明の皮膚洗浄剤組成物には、乳酸、リンゴ酸、及び酒石酸の塩を配合することもできるが、これらの塩では角栓の除去効果は得られない。あくまでも乳酸、リンゴ酸、及び酒石酸から選ばれる1種以上を配合することが必須である。 The component (a) used in the skin cleansing composition of the present invention is selected from lactic acid, malic acid, and tartaric acid, and may be used alone or in combination of two or more. Of these, tartaric acid is particularly preferred. The amount of component (a) is preferably 0.01 to 5% by mass (hereinafter simply referred to as “%”) in the total composition, more preferably 0.1 to 2.5%. If the blending amount is 0.01% or more, the effect of removing horn plugs is sufficiently obtained. Moreover, although the salt of lactic acid, malic acid, and tartaric acid can also be mix | blended with the skin cleaning composition of this invention, the removal effect of a square plug is not acquired with these salts. It is essential to blend at least one selected from lactic acid, malic acid, and tartaric acid.
本発明の皮膚洗浄剤組成物で用いられる成分(b)は、下記一般式(1)で表わされるN−アシルタウリン型陰イオン性界面活性剤である。
R1CO−NR2−CH2CH2SO3M ……… (1)
〔上式中、R1は炭素数7〜19の飽和または不飽和の炭化水素基を表し、R2は水素原子または炭素数1〜3のアルキル基を表し、Mはアルカリ金属原子、アルカリ土類金属原子、アンモニウム、または有機アミンを表す。〕
このようなN−アシルタウリン型陰イオン性界面活性剤の具体例としては、例えば、N−ラウロイル−N−メチルタウリン塩、N−ミリストイル−N−メチルタウリン塩、N−ココイル−N−メチルタウリン塩、N−ラウロイル−N−エチルタウリン塩、N−ミリストイル−N−エチルタウリン塩、N−ココイル−N−エチルタウリン塩、N−ラウロイルタウリン塩、N−ココイルタウリン塩等が挙げられるが、これらに限定されるものではない。上記N−アシルタウリン型陰イオン性界面活性剤は、1種単独又は2種以上を混合して使用することができる。
Component (b) used in the skin cleansing composition of the present invention is an N-acyl taurine type anionic surfactant represented by the following general formula (1).
R 1 CO—NR 2 —CH 2 CH 2 SO 3 M (1)
[In the above formula, R 1 represents a saturated or unsaturated hydrocarbon group having 7 to 19 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, M represents an alkali metal atom, alkaline earth Represents a metal atom, ammonium, or organic amine. ]
Specific examples of such an N-acyl taurine type anionic surfactant include, for example, N-lauroyl-N-methyl taurine salt, N-myristoyl-N-methyl taurine salt, N-cocoyl-N-methyl taurine. Salt, N-lauroyl-N-ethyltaurine salt, N-myristoyl-N-ethyltaurine salt, N-cocoyl-N-ethyltaurine salt, N-lauroyltaurine salt, N-cocoyltaurine salt, etc. It is not limited to. The N-acyl taurine type anionic surfactants can be used singly or in combination of two or more.
上記N−アシルタウリン型陰イオン性界面活性剤の対イオンとしては、アルカリ金属(例えば、リチウム、カリウム、ナトリウム等)、アルカリ土類金属(例えば、カルシウム、マグネシウム等)、アンモニウム、有機アミン(例えば、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン等)が挙げられる。中でもナトリウム、カリウムが好ましい。上記N−アシルタウリン型陰イオン性界面活性剤は市販品を使用することができ、例えばダイヤポンK−SF(日油社製)、アンホレックスAM−1(ミヨシ油脂社製)等が挙げられる。 Examples of the counter ion of the N-acyl taurine type anionic surfactant include alkali metals (for example, lithium, potassium, sodium, etc.), alkaline earth metals (for example, calcium, magnesium, etc.), ammonium, organic amines (for example, Monoethanolamine, diethanolamine, triethanolamine, etc.). Of these, sodium and potassium are preferred. Commercially available products can be used as the N-acyl taurine type anionic surfactant, and examples thereof include Diapon K-SF (manufactured by NOF Corporation), Amphorex AM-1 (manufactured by Miyoshi Oil & Fats Co., Ltd.) and the like.
本発明における成分(b)の配合量は、好ましくは全組成中0.1〜20%であり、より好ましくは1〜15%である。配合量が0.1%以上であれば十分な泡立ちが得られ、20%以下であれば洗浄力が強すぎることもなく、そのため過剰に脱脂され洗い上がり後につっぱり感を感じることもない。 The blending amount of component (b) in the present invention is preferably from 0.1 to 20%, more preferably from 1 to 15%, in the total composition. If the blending amount is 0.1% or more, sufficient foaming can be obtained. If the blending amount is 20% or less, the cleaning power is not too strong.
本発明の皮膚洗浄剤組成物は、上記成分(a)及び(b)を必須成分として含み、pHが3〜5に調整される。pHが3未満では、皮膚刺激を起こす場合があり、pHが5を超えると角栓の除去効果が充分に得られない場合がある。さらに、pHが3〜5に調整されることにより、洗浄により容易に角栓を除去することができる。また、角栓除去することにより、ニキビを予防することができる。尚、pHの測定はJIS K6220による。本発明の洗浄剤組成物には本発明の効果を損なわない範囲において、pH調整剤を適宜用いることができる。pH調整剤としては、乳酸塩、リンゴ酸塩、酒石酸塩、クエン酸塩、コハク酸塩、サリチル酸塩、安息香酸塩等の有機酸塩が好ましい。 The skin cleansing composition of the present invention contains the components (a) and (b) as essential components, and the pH is adjusted to 3-5. If the pH is less than 3, skin irritation may occur, and if the pH exceeds 5, the removal effect of the horn plug may not be sufficiently obtained. Furthermore, when the pH is adjusted to 3 to 5, the horn plug can be easily removed by washing. Moreover, acne can be prevented by removing the square plug. The pH is measured according to JIS K6220. A pH adjuster can be appropriately used in the cleaning composition of the present invention within a range not impairing the effects of the present invention. As the pH adjuster, organic acid salts such as lactate, malate, tartrate, citrate, succinate, salicylate, benzoate and the like are preferable.
本発明の皮膚洗浄剤組成物は、高級脂肪酸塩を含まないことが好ましい。高級脂肪酸塩は、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ヤシ油等の高級脂肪酸と水酸化ナトリウム、水酸化カリウム、モノエタノールアミン、ジエタノールアミン等のアルカリ剤でケン化、又は中和したものであり、高級脂肪酸塩を配合すると起泡性が低下したり、pHが5を超え角栓の除去効果がなくなる場合がある。 The skin cleanser composition of the present invention preferably does not contain a higher fatty acid salt. Higher fatty acid salts are saponified or neutralized with higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, coconut oil, and alkaline agents such as sodium hydroxide, potassium hydroxide, monoethanolamine, diethanolamine, etc. In addition, when a higher fatty acid salt is added, the foamability may be reduced, or the pH may exceed 5 and the removal effect of the horn plug may be lost.
本発明の皮膚洗浄剤組成物は、フォーマー容器に充填して使用することが好ましい。フォーマー容器とは、容器内に充填されている組成物と、空気とを混合して多孔質膜を通過させることにより泡沫状に吐出することができる容器である。具体的には、ポンプフォーマーやスクイズフォーマー等を例示することができる。 The skin cleansing composition of the present invention is preferably used by filling it into a former container. A former container is a container which can be discharged in the form of a foam by mixing the composition filled in the container and air and allowing the porous film to pass through. Specifically, a pump former, a squeeze former, etc. can be illustrated.
また、吐出容器内部の多孔質膜は、一つ又は複数設けられ、それらの膜の孔数は特に限定されないが、キメ細かな泡質にする観点から、100〜400メッシュが好ましく、200〜300メッシュのものを用いるのがより好ましい。 In addition, one or a plurality of porous membranes inside the discharge container are provided, and the number of pores in these membranes is not particularly limited, but is preferably 100 to 400 mesh, and 200 to 300 from the viewpoint of making a fine foam. It is more preferable to use a mesh.
本発明の皮膚洗浄剤組成物は、常法により製造することができ、洗顔、クレンジング、ボディシャンプー、マッサージ料等の皮膚洗浄剤組成物として好適に使用できる。 The skin cleanser composition of the present invention can be produced by a conventional method, and can be suitably used as a skin cleanser composition for facial cleansing, cleansing, body shampoo, massage etc.
本発明の皮膚洗浄剤組成物は、上述した成分の他に、本発明の目的を損なわない範囲で他の成分、例えば、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、ノニオン界面活性剤、水溶性高分子化合物(カチオン性、ノニオン性、アニオン性等を含む)、生理活性成分、酸化防止剤、金属イオン封鎖剤、防腐剤、紫外線吸収剤、香料、保湿剤、塩類、溶媒、中和剤、昆虫忌避剤、酵素等の成分を適宜配合することができる。 In addition to the components described above, the skin cleansing composition of the present invention has other components as long as the object of the present invention is not impaired, such as an anionic surfactant, a cationic surfactant, an amphoteric surfactant, and a nonionic surfactant. Agents, water-soluble polymer compounds (including cationic, nonionic, anionic, etc.), physiologically active ingredients, antioxidants, sequestering agents, preservatives, UV absorbers, perfumes, moisturizers, salts, solvents, Components such as a neutralizing agent, an insect repellent, and an enzyme can be appropriately blended.
上記アニオン性界面活性剤としては、特に限定されるものではないが、例えばN−ヤシ油脂肪酸アシルグリシンカリウム、N−ヤシ油脂肪酸アシルグリシンナトリウム、N−パーム核油脂肪酸アシルグリシンアンモニウム、N−ヤシ油脂肪酸アシルグルタミン酸カリウム、N−ヤシ油脂肪酸アシルグルタミン酸トリエタノールアミン、N−ラウロイルグルタ
ミン酸ナトリウム、N−ラウロイルグルタミン酸トリエタノールアミン、N−ラウロイルアラニンナトリウム、N−ステアロイルアラニンナトリウム、N−ミリストイルアスパラギン酸トリエタノールアミン、α−ラウロイルスルホン酸ナトリウム、ミリストイルアリルスルホン酸ナトリウム、ラウリルナフタレンスルホン酸ナトリウム、ラウリル硫酸トリエタノールアミン、ラウリル硫酸アンモニウム、ラウリルエーテル硫酸ナトリウム、ポリオキシエチレンラウリルエーテル硫酸ナトリウム、ポリオキシエチレンヤシ油脂肪酸アミドエーテル硫酸カリウム等が挙げられ、適宜一種又は二種以上選択して用いればよい。
Although it does not specifically limit as said anionic surfactant, For example, N-coconut oil fatty-acid acylglycine potassium, N-coconut oil fatty-acid acylglycine sodium, N-palm kernel oil fatty-acid acylglycine ammonium, N-coconut Oil fatty acid acyl potassium glutamate, N-coconut oil fatty acid acyl glutamic acid triethanolamine, N-lauroyl glutamate sodium, N-lauroyl glutamate triethanolamine, N-lauroylalanine sodium, N-stearoylalanine sodium, N-myristoyl aspartate triethanol Amine, sodium α-lauroyl sulfonate, sodium myristoyl allyl sulfonate, sodium lauryl naphthalene sulfonate, triethanolamine lauryl sulfate, lauryl Ammonium, sodium lauryl ether sulfate, sodium polyoxyethylene lauryl ether sulfate, polyoxyethylene coconut oil fatty acid amide ether potassium sulfate and the like, may be appropriately selected and used singly or in combination.
上記両性界面活性剤としては、特に限定されるものではないが、例えばラウリン酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルアミノジ酢酸ナトリウム、β−アミノプロピオン酸ナトリウム、N−ラウロイル−N’−カルボキシメチル−N’−ヒドロキシエチルエチレンジアミンナトリウム、ヤシ油脂肪酸ジメチルスルホプロピルベタイン、ラウリルジメチルアミノヒドロキシスルホベタイン、ラウリルヒドロキシスルホベタイン等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The amphoteric surfactant is not particularly limited, and examples thereof include lauric acid amidopropyl betaine, coconut oil fatty acid amidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, and lauryl. Sodium aminodiacetate, sodium β-aminopropionate, N-lauroyl-N′-carboxymethyl-N′-hydroxyethylethylenediamine sodium, coconut oil fatty acid dimethylsulfopropylbetaine, lauryldimethylaminohydroxysulfobetaine, laurylhydroxysulfobetaine, etc. One type or two or more types may be appropriately selected and used.
上記ノニオン界面活性剤としては、特に限定されるものではないが、例えばポリオキシエチレンセチルエーテル、モノステアリン酸ソルビタン、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンモノイソステアレート、ポリオキシエチレンジオレイン酸グリセリル、ヤシ油脂肪酸ジエタノールアミド、ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸N−メチルエタノールアミド、ポリオキシエチレンポリオキシプロピレングリコール、モノラウリン酸ポリエチレングリコール、モノラウリン酸ポリオキシエチレンソルビタン等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The nonionic surfactant is not particularly limited. For example, polyoxyethylene cetyl ether, sorbitan monostearate, polyoxyethylene hydrogenated castor oil, polyoxyethylene monoisostearate, polyoxyethylene dioleic acid Examples include glyceryl, coconut oil fatty acid diethanolamide, coconut oil fatty acid monoethanolamide, coconut oil fatty acid N-methylethanolamide, polyoxyethylene polyoxypropylene glycol, polyethylene glycol monolaurate, polyoxyethylene sorbitan monolaurate, and so on. Alternatively, two or more types may be selected and used.
上記水溶性高分子としては、特に限定されるものではないが、例えば塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体、及びアクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルデンプンリン酸、ポリエチレングリコール、高重合ポリエチレングリコール、ポリビニルアルコール、ポリグルタミン酸、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキルコポリマー、アクリル酸アルキルコポリマー等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The water-soluble polymer is not particularly limited. For example, dimethyldiallylammonium chloride / acrylamide copolymer, acrylamide / acrylic acid / dimethyldiallylammonium chloride copolymer, hydroxyethylcellulose, hydroxypropylcellulose, hydroxy Examples include propylmethylcellulose, hydroxypropyl starch phosphate, polyethylene glycol, highly polymerized polyethylene glycol, polyvinyl alcohol, polyglutamic acid, carboxyvinyl polymer, acrylic acid / alkyl methacrylate copolymer, alkyl acrylate copolymer, etc. Select and use.
上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防御剤、ひきしめ剤、抗酸化剤、保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン類、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、海藻抽出成分、生薬成分や、化合物等が挙げられるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。 Examples of the physiologically active ingredient include substances that impart some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protection agents, tanning agents, antioxidants, moisturizers, blood circulation promoters, antibacterial agents, bactericides, desiccants, cooling agents, warming agents, vitamins, amino acids, Examples include wound healing promoters, stimulus-relieving agents, analgesics, cell activators, enzyme components, and the like. Examples of the physiologically active component include natural plant extract components, seaweed extract components, herbal medicine components, and compounds. Among these, natural plant extract components, seaweed extract components, herbal medicine components are particularly safe. This is preferable.
上記天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、例えばアシタバエキス、アマチャエキス、アルテアエキス、アロエエキス、アンズエキス、イチョウエキス、ウイキョウエキス、ウーロン茶エキス、エイジツエキス、オウゴンエキス、オウバクエキス、オトギリソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カキョクエキス、キウイエキス、キューカンバーエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クロレラエキス、クワエキス、紅茶エキス、酵母エキス、コラーゲン、サルビアエキス、サボンソウエキス、サンザシエキス、ジオウエキス、シコンエキス、シソエキス、シナノ
キエキス、シャクヤクエキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、センキュウエキス、センブリエキス、ダイズエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チンピエキス、トウキエキス、トウニンエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、蜂蜜、ハマメリスエキス、ヒキオコシエキス、ビサボロール、ビワエキス、ブクリョウエキス、プロポリス、ヘチマエキス、ペパーミントエキス、ボダイジュエキス、ホップエキス、マドンナリリー花エキス、マロニエエキス、ムクロジエキス、メリッサエキス、モモエキス、ユキノシタエキス、ユズエキス、ヨモギエキス、ラベンダーエキス、レモンエキス、レンゲソウエキス、ローズマリーエキス、ローヤルゼリーエキス等を挙げることができる。
Examples of the above-mentioned natural plant extract components, seaweed extract components, herbal medicine components include, for example, Ashitaba extract, Achacha extract, Altea extract, Aloe extract, Apricot extract, Ginkgo biloba extract, Fennel extract, Oolong tea extract, Ages extract, Ogon extract, Oat extract, Hypericum extract, Dutch mustard extract, Orange extract, Seawater dried product, Seaweed extract, Hydrolyzed wheat powder, Hydrolyzed silk, Chamomile extract, Carrot extract, Kawara mugwort extract, Licorice extract, Kiwi extract, Cucumber extract, Gardenia extract, Kumazasa extract, Clara extract, Walnut extract, Grapefruit extract, Chlorella extract, Mulberry extract, Black tea extract, Yeast extract, Collagen, Salvia extract, Soap extract, Hawthorn Kiss, Giant extract, Shikon extract, Perilla extract, Linden extract, Peonies extract, Birch extract, Horsetail extract, Horseshoe extract, Hawthorn extract, Horseshoe extract, Pepper extract, Sage extract, Senkyu extract, Assembly extract, Soybean extract , Tiso extract, thyme extract, tea extract, clove extract, chimpi extract, toki extract, tonin extract, dokudami extract, tomato extract, natto extract, carrot extract, garlic extract, wild rose extract, honey, hamamelis extract, cassava extract, bisabolol, loquat extract, bukuryu Extract, Propolis, Loofah extract, Peppermint extract, Bodaige extract, Hop extract, Madonna lily flower Ex , Mention may be made of horse chestnut extract, Sapindus extract, Melissa extract, peach, strawberry geranium extract, Yuzuekisu, mugwort extract, lavender extract, lemon extract, Astragalus Saw extract, rosemary extract, royal jelly extract, and the like.
また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えばデオキシリボ核酸、ムコ多糖類、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜などの生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイなどの保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リン脂質などの油性成分、ε−アミノカプロン酸、グリチルリチン酸、β−グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4−アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α−ヒドロキシ酸、β−ヒドロキシ酸などの細胞賦活剤、γ−オリザノール、ビタミンE誘導体などの血行促進剤、イソプロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム等の殺菌剤、l−メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体等の創傷治癒剤等が挙げられる。 Examples of components other than the above-mentioned natural plant extract components, seaweed extract components, and herbal medicine components include deoxyribonucleic acid, mucopolysaccharide, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, hydrolyzed eggshell membrane Moisturizing ingredients such as biopolymers such as amino acids, sodium lactate, urea, sodium pyrrolidone carboxylate, betaine, whey, oily ingredients such as sphingolipids, ceramides, cholesterol, cholesterol derivatives, phospholipids, ε-aminocaproic acid, glycyrrhizic acid , Β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, hydrocortisone and other anti-inflammatory agents, vitamins (A, B2, B6, C, D, E), calcium pantothenate, biotin, nicotinamide, vitamin C esters, etc. Active ingredients such as amines, allantoin, diisopropylamine dichloroacetate, 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as tocopherol, carotenoid, flavonoid, tannin, lignan, saponin, α-hydroxy acid, β-hydroxy acid, etc. Cell activators, blood circulation promoters such as γ-oryzanol, vitamin E derivatives, fungicides such as isopropylmethylphenol, triclosan, hinokitiol, benzalkonium chloride, cooling agents such as l-menthol and mint oil, retinol, retinol derivatives And wound healing agents.
次に本発明の皮膚洗浄剤組成物について、実施例をもって詳細に説明するが、本発明はこれにより限定されるものではない。なお、以下の全ての実施例及び比較例における配合量は質量%である。 Next, although the skin cleansing composition of this invention is demonstrated in detail with an Example, this invention is not limited by this. In addition, the compounding quantity in all the following examples and comparative examples is the mass%.
・実施例1〜11、及び比較例1〜8
表1に示す組成の皮膚洗浄剤組成物を常法に準じて調製し、容量200mLのポンプフォーマー型容器(200メッシュ2枚使用)に200mL充填し、ポンプフォーマータイプの皮膚洗浄剤組成物を得た。得られた皮膚洗浄剤組成物について下記評価を行い、その結果を表1に併せて示した。なお、クエン酸ナトリウム(pH調整用)の配合量は各pH値に調整する必要量を適量と表記した。
-Examples 1-11 and Comparative Examples 1-8
A skin cleanser composition having the composition shown in Table 1 was prepared according to a conventional method, and 200 mL of a 200 mL capacity pump former type container (using two 200 mesh) was filled. Got. The obtained skin cleansing composition was evaluated as follows, and the results are also shown in Table 1. In addition, the compounding quantity of sodium citrate (for pH adjustment) described the required quantity adjusted to each pH value as an appropriate quantity.
(1)室温での泡立ち、及び泡のクリーミー性(吐出時、及び吐出から1分経過後)
室温にてパネラー20名がそれぞれ通常のスクイズ動作を行い、内容物を吐出させて手に取り、泡吐出時と、泡吐出から1分経過後に、泡の見た目と感触により、泡のクリーミー性を下記評価基準に従って室温にて官能評価した。
<評価基準>
◎:泡がかなりクリーミーで良好
○:泡がクリーミーで良好
△:泡がやや粗い、やや柔らかすぎる
×:泡が粗い、柔らかすぎる
(1) Foaming at room temperature and creaminess of foam (at the time of discharge and after 1 minute from discharge)
20 panelists perform normal squeeze operations at room temperature, discharge the contents and pick them up in their hands. After the foam is discharged and 1 minute after the foam is discharged, the appearance and feel of the foam increases the creaminess of the foam. Sensory evaluation was performed at room temperature according to the following evaluation criteria.
<Evaluation criteria>
◎: Foam is quite creamy and good ○: Foam is creamy and good △: Foam is slightly rough and slightly soft ×: Foam is too rough and soft
(2)使用時の皮膚の刺激性
20名の専門パネルに、3gの皮膚洗浄剤組成物を用いて、皮膚洗浄剤組成物を直接顔面に塗布してから洗顔した際の刺激性を下記評価基準に従って室温にて官能評価した。
<評価基準>
◎:使用時に刺激がないと答えた被験者の数が18人以上
○:使用時に刺激がないと答えた被験者の数が14〜17人
△:使用時に刺激がないと答えた被験者の数が9〜13人
×:使用時に刺激がないと答えた被験者の数が8人未満
(2) Skin irritation at the time of use The following evaluation was made on the irritation when washing the face after applying the skin cleanser composition directly to the face using 3 g of the skin cleanser composition on 20 professional panels. Sensory evaluation was performed at room temperature according to the standard.
<Evaluation criteria>
◎: The number of subjects who answered that there was no irritation at the time of use was 18 or more ○: The number of subjects who answered that there was no irritation at the time of use 14-17 people △: The number of subjects who answered that there was no irritation at the time of use 9 ~ 13 people ×: The number of subjects who answered that there was no irritation during use was less than
(3)角栓除去効果
健常パネル5名に、1gの皮膚洗浄剤組成物を鼻部分のみに塗布し、30秒間マッサージを行い、その後、水で1分間すすいだ。洗浄前後の小鼻に存在する角栓数をそれぞれ計測し、下記式(1)により角栓除去率を求め評価した。
◎:角栓除去率が60%以上
○:角栓除去率が40%以上60%未満
△:角栓除去率が20%以上40%未満
×:角栓除去率が20%未満
(3) Removal effect of horn plug For 5 healthy panels, 1 g of the skin cleanser composition was applied only to the nose portion, massaged for 30 seconds, and then rinsed with water for 1 minute. The number of horn plugs present in the nose before and after washing was measured, and the horn plug removal rate was calculated and evaluated by the following formula (1).
◎: Square plug removal rate is 60% or more ○: Square plug removal rate is 40% or more and less than 60% △: Square plug removal rate is 20% or more and less than 40% ×: Square plug removal rate is less than 20%
(4)低温安定性
皮膚洗浄剤組成物を50mL透明サンプル管にそれぞれ充填し、5℃に1週間保存して、下記の基準で評価した。
<評価基準>
◎:外観が透明で析出物なし
○:ごく微かに濁っているが析出物なし
△:やや白濁し、析出物が少しある
×:析出物が多く認められる
(4) Low temperature stable skin cleanser compositions were each filled into 50 mL transparent sample tubes, stored at 5 ° C. for 1 week, and evaluated according to the following criteria.
<Evaluation criteria>
◎: Appearance is transparent and there is no precipitate ○: Very slightly turbid but no precipitate △: Slightly cloudy with some precipitate ×: Many precipitates are observed
表1より明らかなように、本発明の成分を用いた実施例1〜11の皮膚洗浄剤組成物は比較例1〜8の組成物に比べていずれも優れた性能を見出した。 As is clear from Table 1, the skin cleanser compositions of Examples 1 to 11 using the components of the present invention all found superior performance as compared to the compositions of Comparative Examples 1 to 8.
以下、本発明の皮膚洗浄剤組成物のその他の処方例を実施例12〜14として挙げる。 Hereinafter, other prescription examples of the skin cleansing composition of the present invention are listed as Examples 12 to 14.
実施例12 抗炎症剤及び殺菌剤配合皮膚洗浄剤組成物
(1)酒石酸 1.0
(2)N−ココイル−N−メチルタウリンナトリウム 6.0
(3)ラウリルヒドロキシスルホベタイン 3.0
(4)モノラウリン酸ポリオキシエチレンソルビタン 5.0
(5)グリセリン 10.0
(6)ジプロピレングリコール 5.0
(7)ホップエキス 1.0
(8)グリコシルトレハロース 0.5
(9)ウーロン茶エキス 0.1
(10)加水分解コラーゲン液 0.1
(11)ヒアルロン酸ナトリウム 0.1
(12)N−アセチルグルコサミン 0.1
(13)ローヤルゼリーエキス 0.1
(14)レモンエキス 0.1
(15)ヒオウギエキス 0.1
(16)ダイズエキス 0.1
(20)グリチルリチン酸ジカリウム 0.1
(21)イソプロピルメチルフェノール 0.1
(22)クエン酸ナトリウム 2.3
(23)エデト酸二ナトリウム 0.1
(24)オレンジ油 0.2
(25)精製水 残 余
(pH 4.5)
Example 12 Skin Cleanser Composition Containing Anti-Inflammatory Agent and Bactericide (1) Tartaric Acid 1.0
(2) N-cocoyl-N-methyltaurine sodium 6.0
(3) Lauryl hydroxysulfobetaine 3.0
(4) Polyoxyethylene sorbitan monolaurate 5.0
(5) Glycerin 10.0
(6) Dipropylene glycol 5.0
(7) Hop extract 1.0
(8) Glycosyl trehalose 0.5
(9) Oolong tea extract 0.1
(10) Hydrolyzed collagen solution 0.1
(11) Sodium hyaluronate 0.1
(12) N-acetylglucosamine 0.1
(13) Royal jelly extract 0.1
(14) Lemon extract 0.1
(15) Hinogi extract 0.1
(16) Soybean extract 0.1
(20) Dipotassium glycyrrhizinate 0.1
(21) Isopropylmethylphenol 0.1
(22) Sodium citrate 2.3
(23) Disodium edetate 0.1
(24) Orange oil 0.2
(25) Purified water residue (pH 4.5)
実施例1〜11と同様の方法により、ポンプフォーマータイプの皮膚洗浄剤組成物を調製した。室温での泡立ち、泡のクリーミー性、皮膚の刺激性、角栓除去効果、製剤の低温安定性について評価したところ、いずれの特性も優れており良好な結果を得た。 Pump former type skin cleansing compositions were prepared in the same manner as in Examples 1-11. Evaluation of foaming at room temperature, foam creaminess, skin irritation, horn plug removal effect, and low-temperature stability of the preparations showed excellent properties and excellent results.
実施例13 洗顔フォーム
(1)酒石酸 3.0
(2)N−ココイル−N−メチルタウリンナトリウム 6.0
(3)2−アルキル−N−カルボキシメチル−
N−ヒドロキシエチルイミダゾリウムベタイン 2.0
(4)ヤシ油脂肪酸モノエタノールアミド 0.5
(5)グリセリン 15.0
(6)塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体 0.3
(7)アクリル酸アルキルコポリマー 2.0
(8)ポリグルタミン酸 0.5
(9)ダイズエキス 0.1
(10)バラエキス 0.1
(11)グリコシルトレハロース 0.5
(12)ヒアルロン酸ナトリウム 0.1
(13)ユキノシタエキス 0.1
(14)モモ葉エキス 0.1
(15)アロエベラ葉エキス 0.1
(16)N−アセチルグルコサミン 0.1
(17)カニナバラ果実エキス 0.1
(18)水酸化ナトリウム 0.3
(19)クエン酸ナトリウム 7.0
(20)エデト酸二ナトリウム 0.1
(21)香料 0.2
(22)精製水 残 余
(pH 4.0)
Example 13 Face Wash Foam (1) Tartaric Acid 3.0
(2) N-cocoyl-N-methyltaurine sodium 6.0
(3) 2-alkyl-N-carboxymethyl-
N-hydroxyethylimidazolium betaine 2.0
(4) Palm oil fatty acid monoethanolamide 0.5
(5) Glycerin 15.0
(6) Dimethyldiallylammonium chloride / acrylamide copolymer 0.3
(7) Alkyl acrylate copolymer 2.0
(8) Polyglutamic acid 0.5
(9) Soybean extract 0.1
(10) Rose extract 0.1
(11) Glycosyl trehalose 0.5
(12) Sodium hyaluronate 0.1
(13) Yukinoshita extract 0.1
(14) Peach leaf extract 0.1
(15) Aloe vera leaf extract 0.1
(16) N-acetylglucosamine 0.1
(17) Canina rose fruit extract 0.1
(18) Sodium hydroxide 0.3
(19) Sodium citrate 7.0
(20) Edetate disodium 0.1
(21) Fragrance 0.2
(22) Purified water residue (pH 4.0)
常法により上記組成の洗顔フォームを調製し、室温での泡立ち、泡のクリーミー性、皮膚
の刺激性、角栓除去効果、製剤の低温安定性について評価したところ、いずれの特性も優れており良好な結果を得た。
A facial cleansing foam with the above composition was prepared by a conventional method and evaluated for foaming at room temperature, foam creaminess, skin irritation, keratin plug removal effect, and low-temperature stability of the preparation. Results were obtained.
実施例14 ボディシャンプー
(1)乳酸 0.5
(2)N−ラウロイル−N−メチルタウリンナトリウム 15.0
(3)ポリオキシエチレンラウリルエーテル硫酸ナトリウム 3.0
(4)ヤシ油脂肪酸アミドプロピルベタイン 2.0
(5)グリセリン 15.0
(6)塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体 0.3
(7)ヒドロキシプロピルメチルセルロース 1.0
(8)桃葉エキス 1.0
(9)アロエベラ葉エキス 0.1
(10)グリコシルトレハロース 0.1
(11)カモミラエキス 0.1
(12)ノバラエキス 0.1
(13)シルクエキス 0.1
(14)N−アセチルグルコサミン 0.1
(15)キウイエキス 0.1
(16)アンズ果実エキス 0.1
(17)ユーカリエキス 0.1
(18)塩化ナトリウム 0.1
(19)エデト酸二ナトリウム 0.1
(20)香料 0.5
(21)精製水 残 余
(pH 3.5)
Example 14 Body Shampoo (1) Lactic acid 0.5
(2) N-lauroyl-N-methyltaurine sodium 15.0
(3) Polyoxyethylene lauryl ether sodium sulfate 3.0
(4) Palm oil fatty acid amidopropyl betaine 2.0
(5) Glycerin 15.0
(6) Dimethyldiallylammonium chloride / acrylamide copolymer 0.3
(7) Hydroxypropyl methylcellulose 1.0
(8) Peach leaf extract 1.0
(9) Aloe vera leaf extract 0.1
(10) Glycosyl trehalose 0.1
(11) Chamomile extract 0.1
(12) Novara extract 0.1
(13) Silk extract 0.1
(14) N-acetylglucosamine 0.1
(15) Kiwi extract 0.1
(16) Apricot fruit extract 0.1
(17) Eucalyptus extract 0.1
(18) Sodium chloride 0.1
(19) Edetate disodium 0.1
(20) Fragrance 0.5
(21) Purified water residue (pH 3.5)
常法により上記組成のボディシャンプーを調製し、室温での泡立ち、泡のクリーミー性、皮膚の刺激性、角栓除去効果、製剤の低温安定性について評価したところ、いずれの特性も優れており良好な結果を得た。 A body shampoo with the above composition was prepared by a conventional method and evaluated for foaming at room temperature, foam creaminess, skin irritation, keratin plug removal effect, and low-temperature stability of the preparation. Results were obtained.
Claims (3)
(a)乳酸、リンゴ酸、及び酒石酸から選ばれる1種以上
(b)下記一般式(1)で表されるN−アシルタウリン型陰イオン性界面活性剤
R1CO−NR2−CH2CH2SO3M ……… (1)
〔上式中、R1は炭素数炭素数7〜19の飽和または不飽和の炭化水素基を表し、R2は水素原子または炭素数1〜3のアルキル基を表し、Mはアルカリ金属原子、アルカリ土類金属原子、アンモニウム、有機アンモニウム、または塩基性アミノ酸を表す。〕 A skin cleansing composition for removing horn plugs, comprising the following components (a) and (b) and having a pH of 3 to 4.6.
(A) One or more kinds selected from lactic acid, malic acid, and tartaric acid (b) N-acyl taurine type anionic surfactant represented by the following general formula (1) R 1 CO—NR 2 —CH 2 CH 2 SO 3 M (1)
[In the above formula, R 1 represents a saturated or unsaturated hydrocarbon group having 7 to 19 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, M is an alkali metal atom, Represents an alkaline earth metal atom, ammonium, organic ammonium, or basic amino acid. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013256864A JP6183849B2 (en) | 2013-12-12 | 2013-12-12 | Skin cleanser composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013256864A JP6183849B2 (en) | 2013-12-12 | 2013-12-12 | Skin cleanser composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015113307A JP2015113307A (en) | 2015-06-22 |
JP6183849B2 true JP6183849B2 (en) | 2017-08-23 |
Family
ID=53527441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013256864A Active JP6183849B2 (en) | 2013-12-12 | 2013-12-12 | Skin cleanser composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6183849B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6134837B1 (en) * | 2016-04-20 | 2017-05-24 | クラシエホームプロダクツ株式会社 | Liquid detergent composition |
JP6469935B1 (en) | 2017-04-10 | 2019-02-13 | 花王株式会社 | How to remove horn plugs |
US11224561B2 (en) | 2017-04-10 | 2022-01-18 | Kao Corporation | Skin cleansing composition |
EP3610849A4 (en) | 2017-04-10 | 2021-01-13 | Kao Corporation | Keratin plug removal method |
JP7137338B2 (en) | 2017-04-10 | 2022-09-14 | 花王株式会社 | skin cleanser composition |
WO2018190263A1 (en) | 2017-04-10 | 2018-10-18 | 花王株式会社 | Skin cleanser composition |
WO2018190266A1 (en) | 2017-04-10 | 2018-10-18 | 花王株式会社 | Skin cleanser composition |
JP7105037B2 (en) * | 2017-05-16 | 2022-07-22 | 小林製薬株式会社 | detergent composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3084086B2 (en) * | 1991-06-10 | 2000-09-04 | 花王株式会社 | Keratin plug regeneration inhibitor |
JP3315535B2 (en) * | 1994-08-30 | 2002-08-19 | 株式会社成和化成 | Cosmetic base material |
US6071541A (en) * | 1998-07-31 | 2000-06-06 | Murad; Howard | Pharmaceutical compositions and methods for managing skin conditions |
JP4190809B2 (en) * | 2002-06-25 | 2008-12-03 | 株式会社資生堂 | Cleaning composition |
JP3828055B2 (en) * | 2002-08-12 | 2006-09-27 | 花王株式会社 | Cleansing cosmetics |
JP4830305B2 (en) * | 2005-01-27 | 2011-12-07 | 日油株式会社 | Weakly acidic foam detergent composition |
MY155245A (en) * | 2007-08-30 | 2015-09-30 | Lion Corp | Skin cleansing agent, and skin cleansing method using the same |
JP2009221138A (en) * | 2008-03-14 | 2009-10-01 | Kose Corp | Detergent composition |
ITMI20080444A1 (en) * | 2008-03-17 | 2009-09-18 | Giuliani Spa | AGENTS TO COUNTER AND REDUCE THE IRRITATING ACTION OF TENSIOUS ACTIVE IN COMPOSITIONS TO BE APPLIED ON THE SKIN FOR THE CARE OR DETERGENT OF THE FACE AND THE BODY |
JP5631724B2 (en) * | 2010-12-24 | 2014-11-26 | 花王株式会社 | Skin disinfectant cleaner composition |
JP5400196B2 (en) * | 2011-08-03 | 2014-01-29 | 株式会社 資生堂 | Square plug regeneration inhibitor |
JP5400105B2 (en) * | 2011-08-03 | 2014-01-29 | 株式会社 資生堂 | Square plug regeneration suppression method and square plug regeneration suppression kit |
TWI481417B (en) * | 2011-08-03 | 2015-04-21 | Shiseido Co Ltd | Inhibiting preparation against re-growth of pore-clogging plug, method of inhibiting re-growth of pore-clogging plug, and a kit for the use of inhibiting re-growth of pore-clogging plug |
-
2013
- 2013-12-12 JP JP2013256864A patent/JP6183849B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11911498B2 (en) | 2020-06-01 | 2024-02-27 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Also Published As
Publication number | Publication date |
---|---|
JP2015113307A (en) | 2015-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6183849B2 (en) | Skin cleanser composition | |
JP2013163659A (en) | Skin detergent composition | |
JP6134837B1 (en) | Liquid detergent composition | |
JP2014125435A (en) | Skin cleanser composition | |
JP6062279B2 (en) | Liquid detergent composition | |
JP2017171625A (en) | Cleanser composition | |
JP2013163658A (en) | Skin detergent composition | |
JP2014156538A (en) | Liquid detergent composition | |
JP6812099B2 (en) | Skin cleanser | |
JP2008094724A (en) | Skin cleanser composition | |
JP7217925B2 (en) | skin cleanser composition | |
JP2012149198A (en) | Skin detergent composition | |
JP2014129244A (en) | Skin cleanser composition | |
JP2016094375A (en) | Liquid detergent composition for foamer container | |
CN112449594A (en) | Skin cleanser composition | |
JP2014125434A (en) | Skin cleanser composition | |
JP6990496B2 (en) | Detergent composition | |
JP6437289B2 (en) | Cleaning composition | |
JP7204162B2 (en) | detergent composition | |
JP2016124828A (en) | Improving agent, preventing agent, and detergent composition for senile xerosis | |
CN112449593A (en) | Skin cleanser composition | |
JP6833320B2 (en) | Skin cleanser composition | |
JP6366437B2 (en) | Skin cleanser composition | |
JP6828889B2 (en) | Cleaning agent composition | |
JP2022016944A (en) | Cleansing cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160524 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170420 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170703 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170706 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170719 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170719 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6183849 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |